Bio-Techne (NASDAQ: TECH) reported Q1 EPS of $0.98, $0.02 better than the analyst estimate of $0.96. Revenue for the quarter came in at $163 million versus the consensus estimate of $161.67 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.